We are live on ! Find out more
Connor, Clark & Lunn Investment Management (CC&L)

Connor, Clark & Lunn Investment Management (CC&L) Portfolio holdings

AUM $43.4B
1-Year Est. Return 51.29%
This Fund
S&P 500
This Quarter Est. Return
+1.73%
1 Year Est. Return
+51.29%
3 Year Est. Return
+133.48%
5 Year Est. Return
+173.9%
10 Year Est. Return
+551.09%
AUM
$22.9B
AUM Growth
+$801M
Cap. Flow
+$1.26B
Cap. Flow %
5.48%
Top 10 Hldgs %
26.16%
Holding
1,655
New
269
Increased
651
Reduced
446
Closed
272

Top Buys

Rank Stock Value
1
FNV icon
Franco-Nevada
FNV
+$159M
2
TRP icon
TC Energy
TRP
+$105M
3
MRVL icon
Marvell Technology
MRVL
+$92.4M
4
INFY icon
Infosys
INFY
+$83.4M
5
PAAS icon
Pan American Silver
PAAS
+$81.1M

Sector Composition

Rank Sector Weight
1 Financials 23.76%
2 Technology 17.69%
3 Industrials 12.67%
4 Energy 11.54%
5 Materials 11.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATRC icon
401
AtriCure
ATRC
$2.21B
$7.21M 0.03%
223,569
+41,847
+23% +$1.55M
HUT
402
Hut 8
HUT
$10.2B
$7.19M 0.03%
618,930
-272,900
-31% -$5.04M
NWG icon
403
NatWest
NWG
$76.9B
$7.16M 0.03%
600,743
+550,764
+1,102% +$6.17M
DDL
404
Dingdong
DDL
$512M
$7.13M 0.03%
2,641,834
+621,018
+31% +$2.02M
BSAC icon
405
Banco Santander Chile
BSAC
$16.1B
$7.1M 0.03%
311,277
+52,900
+20% +$1.13M
ACHC icon
406
Acadia Healthcare
ACHC
$2.82B
$7.1M 0.03%
234,031
-8,953
-4% -$341K
HTGC icon
407
Hercules Capital
HTGC
$3.17B
$7.1M 0.03%
369,368
+206,066
+126% +$4.16M
CIB icon
408
Grupo Cibest SA
CIB
$22.7B
$7.09M 0.03%
176,281
+11,849
+7% +$465K
CGNT icon
409
Cognyte Software
CGNT
$692M
$7.08M 0.03%
908,077
+112,530
+14% +$1.03M
AGX icon
410
Argan
AGX
$7.84B
$7.06M 0.03%
53,831
-18,698
-26% -$2.61M
HRTG icon
411
Heritage Insurance Holdings
HRTG
$989M
$7M 0.03%
485,631
+37,763
+8% +$454K
HON icon
412
Honeywell
HON
$74.2B
$6.95M 0.03%
+34,810
New +$7.04M
VCYT icon
413
Veracyte
VCYT
$3.42B
$6.94M 0.03%
234,196
-45,135
-16% -$1.72M
HUBB icon
414
Hubbell
HUBB
$26.8B
$6.93M 0.03%
+20,937
New +$8.11M
GNW icon
415
Genworth Financial
GNW
$3.77B
$6.83M 0.03%
963,734
+164,192
+21% +$1.14M
AM icon
416
Antero Midstream
AM
$10.5B
$6.79M 0.03%
377,371
+136,448
+57% +$2.26M
HRI icon
417
Herc Holdings
HRI
$5.64B
$6.79M 0.03%
+50,586
New +$8.62M
XIFR
418
XPLR Infrastructure LP
XIFR
$1.09B
$6.79M 0.03%
714,539
+411,339
+136% +$4.66M
OTEX icon
419
Open Text
OTEX
$6.02B
$6.77M 0.03%
268,300
-39,000
-13% -$1.07M
NOA
420
North American Construction
NOA
$389M
$6.76M 0.03%
428,800
+1,647
+0.4% +$30.5K
ACN icon
421
Accenture
ACN
$109B
$6.7M 0.03%
21,463
-3,497
-14% -$1.24M
SMWB icon
422
Similarweb
SMWB
$789M
$6.67M 0.03%
806,174
+128,709
+19% +$1.59M
UTHR icon
423
United Therapeutics
UTHR
$21.5B
$6.66M 0.03%
21,590
+7,058
+49% +$2.42M
OSCR icon
424
Oscar Health
OSCR
$9.5B
$6.58M 0.03%
501,972
+79,979
+19% +$1.19M
CMPR icon
425
Cimpress
CMPR
$2.37B
$6.57M 0.03%
145,361
+8,637
+6% +$485K

Similar funds

Connor, Clark & Lunn Investment Management (CC&L)'s Q1 2025 Portfolio in Review

As of Q1 2025, Connor, Clark & Lunn Investment Management (CC&L) held 1,655 positions worth $22.9B, up 3.6% from $22.1B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Connor, Clark & Lunn Investment Management (CC&L) deployed $1.26B of net new capital in Q1 2025, opening 269 new positions and adding to 651 existing holdings. Its largest new stake was Advanced Micro Devices: 709,028 shares worth $72.8M.

By sector, the portfolio is most concentrated in Financials at 24% of assets, down from 26% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Celestica, an estimated $111M trimmed.

  • Connor, Clark & Lunn Investment Management (CC&L)'s largest Q1 2025 buy was Advanced Micro Devices: 709,028 shares worth $72.8M.
  • Connor, Clark & Lunn Investment Management (CC&L) added most to Franco-Nevada in Q1 2025, an estimated $159M increase.
  • Connor, Clark & Lunn Investment Management (CC&L)'s biggest Q1 2025 reduction was Celestica, cutting an estimated $111M.
  • Connor, Clark & Lunn Investment Management (CC&L) fully exited Edwards Lifesciences in Q1 2025, selling an estimated $28.1M.
  • Connor, Clark & Lunn Investment Management (CC&L)'s ten largest holdings make up 26% of its $22.9B portfolio in Q1 2025.
  • Connor, Clark & Lunn Investment Management (CC&L) opened 269 new positions and closed 272 in Q1 2025.
  • Connor, Clark & Lunn Investment Management (CC&L)'s portfolio value rose 3.6% quarter-over-quarter to $22.9B.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q1 2025, filed 12 May 2025.